Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
For our US-based readers … It appears that Rep. Kucinich’s statements on his web site (reported on this web site a few days ago) are something of a political simplification of reality.
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, USPSTF | 1 Comment »
Some readers may want to review the article on the Reuters web site entitled “Health panel takes heat on cancer screening advice.”
Filed under: Diagnosis, Risk | Tagged: screening, USPSTF | 8 Comments »
On November 8, the American Urological Asociation (AUA) issued its full, formal comment letter on the US Preventive Services Task Force (USPSTF)’s draft recommendation of a “D” grade for the use of PSA screening in healthy men with no symptoms of prostate cancer. The AUA also issued a formal statement for the media.
Filed under: Diagnosis, Risk | Tagged: AUA, Diagnosis, PSA, risk, screening, USPSTF | 3 Comments »
An article by a highly regarded specialist in medical oncology in the most recent issue of The ASCO Post discusses recent recommendations from the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: Diagnosis, opinion, recommendation, risk, USPSTF | 11 Comments »
In addition to the formal letter submitted to the U.S. Preventive Services Task Force (USPSTF), and noted on this web site on Friday, the Prostate Cancer Roundtable has, this morning, also issued a media release, signed by the same 10 members of the Roundtable.
Filed under: Diagnosis, Risk | Tagged: recommendation, Roundtable, USPSTF | 5 Comments »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings!
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
Ten members of the Prostate Cancer Roundtable have today submitted a joint letter to the U.S. Preventive Services Task Force commenting on the recent draft recommendation of a “D” grade for use of the PSA test in screening for prostate cancer among men who do not have symptoms that are highly suspicious for prostate cancer, [...]
Filed under: Diagnosis, Risk | Tagged: PSA testing, risk, screening, USPSTF | 1 Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
The following editorial commentary related to the USPSTF recommendation was published on Friday, October 13, 2011 on the UroToday web site and is reproduced here with the permission of UroToday. The commentary was written by Alan Wein, MD,
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, recommendation, risk, screening, testing, USPSTF | 6 Comments »
Readers might want to read an article by Ralph de Vere White, MD, the Director of the UC Davis Cancer Center at the University of California Davis in Sacramento, California. Dr. de Vere White is a respected urologic oncologist known to have a strong commitment to shared decision making with patients on issues of cancer risk [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, recommendation, risk, USPSTF | 10 Comments »
As one might expect, there is an extremely diverse (and conflicting) range of reactions to the USPSTF recommendation that routine PSA testing of uninformed men is not supported by good evidence and should no longer be considered as appropriate “standard” practice unless there has been a prior discussion of the risks and benefits of the [...]
Filed under: Diagnosis, Management, Risk | Tagged: benefit, cost, coverage, PSA, risk, USPSTF | 6 Comments »
The media – over the past few days — has taken every opportunity to “stoke the furore” about the USPSTF’s recommendation that PSA screening (of all men aged 50 to 75 years of age, or thereabouts) is not justified by the available data.
Filed under: Diagnosis, Management, Risk | Tagged: PSA, risk, testing, USPSTF | 3 Comments »
The “New” Prostate Cancer InfoLink has replicated below, in its entirety, a media release issued early this morning by the Prostate Cancer Foundation. We believe that this is precisely the correct response to the new USPSTF recommendation: acknowledgement of the realities of the USPSTF’s factually accurate recommendation and the recognition by the USPSTF that PSA [...]
Filed under: Diagnosis, Management, Risk | Tagged: PCF, Prostate cancer Foundation, screening, testing, USPSTF | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site
Lack of transparency re public “input” to USPSTF is rather sad
According to a new article by Andy Pollack on the New York Times Health blog just before 1:00 p.m. EST today, the U.S. Preventive Services Task Force (USPSTF) has managed to add to public confusion about its process for what was originally described as public “comment” on current draft recommendations (regarding screening tests for prostate [...]
Filed under: Diagnosis, Risk | Tagged: public comment, recommendation, transparency, USPSTF | 8 Comments »